Maquet Servo
VENTILATION, SERVO-i ONE SYSTEM, MULTIPLE OPTIONS
Leading the way: MAQUET is a premier international provider of medical technology solutions. Focused on the OR and ICU, the company is committed to developing solutions that improve patient care.
MAQUET draws on many years’ experience in supplying state-of-the-art ventilator systems. Since the introduction of the first SERVO ventilator in 1971, MAQUET has delivered more than 100,000 units and SERVO has become the world’s number one ventilation brand.
SERVO-i® now sets the standard for critical care ventilation. It delivers a high level of clinical performance to help clinicians provide the best possible care for neonatal, pediatric and adult patients.
SERVO-i is also easy to learn and use. Designed to be
easily upgradeable, it grows with the hospital’s changing needs to ensure lasting value.
MAQUET – The Gold Standard
Designed to meet your
Current & Future needs
All-in-one platform: SERVO-i combines a high level of clinical performance for invasive, non-invasive or neurally controlled ventilation with outstanding mobility and cost efficiency. It features all the modes you would expect from an advanced ventilation system in one adaptable platform.
Four basic configurations are available: SERVO-i Infant, SERVO-i Adult, and two editions of SERVO-i Universal for all patient categories. SERVO-i Infant and SERVO-i Adult can always be upgraded to SERVO-i Universal.
All SERVO-i ventilatory configurations are effective for bedside use and most of them are also available in MR edition.
Servolution
Comprehensive Therapeutic Packages
SERVOlution™: MAQUET has introduced four comprehensive therapeutic packages for the SERVO-i. Each gives clinicians the ventilator capabilities to meet a specific therapeutic challenge.
SERVOlution SYNCHRONIZE provides tools to objectively assess patient respiratory contribution and comfort levels and respond accordingly – guided by evidence.
SERVOlution PROTECT offers tools to assess lung stress and implement
lung protective interventions. NAVA ensures early respiratory muscle reconditioning in spontaneously breathing patients.
SERVOlution RELIEVE supports obstructive patients with noninvasive ventilation and quantitative assessment tools. NAVA® together with extracorporeal CO2 removal opens up a new treatment option for severe COPD patients.
SERVOlution BABY is configured with the assessment and intervention tools to address the unique support, protection and comfort needs of babies.